Roche Drug Pulled, PTV News: Mar 08, 2010

Episode Loading...

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Roche Drug Pulled, PTV News: Mar 08, 2010
Released on: March 08, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Follow us:
  • Summary
  • Transcript
  • Participants
  • Company
Rheumatoid arthritis treatment causes deaths
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Josef Walker
Senior Analyst

Josef has conducted in-depth projects for numerous companies from the biotech, pharmaceutical and medical device sectors and has extensive experience in deal and trend analysis, market research, benchmarking, transactions, litigation support and pipeline assessments. Josef has a degree in Molecular Biology from the University of Leicester and a PhD in Molecular Immunology from University College London. He previously engaged in postdoctoral research on the interactions between human dendritic cells and type I interferons at the Edward Jenner Institute for Vaccine Research.
F. Hoffmann-La Roche
F. Hoffmann–La Roche Ltd. is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange.

The company headquarters are located in Basel and the company has many sites around the world - including: Nutley, NJ, Palo Alto, California, Pleasanton, Branchburg, Fishers, Indiana, Florence, South Carolina, Boulder, Colorado and Ponce, Puerto Rico in the US, Welwyn Garden City and Burgess Hill in the UK, Clarecastle in Ireland, Mannheim and Penzberg in Germany, and Shanghai in China.

The company also owns the American biotechnology company Genentech, which is a wholly owned subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals.